RNA-binding proteins: Splicing factors and disease

Biomolecules

Volumn 5, Issue 2, 2015, Pages 893-909

  Fredericks, Alger M ^a   Cygan, Kamil J ^a,b   Brown, Brian A ^a   Fairbrother, William G ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Motif; RNA binding proteins; Splicing

Indexed keywords

INTEIN; RIBONUCLEOPROTEIN; RNA BINDING PROTEIN; TRANS ACTING FACTOR;

GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNE DYSREGULATION; MUTATION RATE; MYOTONIC DYSTROPHY; NONHUMAN; REVIEW; RNA SPLICING; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPINOCEREBELLAR DEGENERATION; SPLICEOSOME; SPLICING DEFECT; ANIMAL; GENETIC DISORDER; GENETICS; METABOLISM;

EUKARYOTA;

ANIMALS; GENETIC DISEASES, INBORN; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA SPLICING; RNA-BINDING PROTEINS; SPLICEOSOMES;

EID: 85012049346     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5020893     Document Type: Review

References (98)

1. Pan, Q.; Shai, O.; Lee, L.J.; Frey, B.J.; Blencowe, B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 2008, 40, 1413-1415.
2. Wang, E.T.; Sandberg, R.; Luo, S.; Khrebtukova, I.; Zhang, L.; Mayr, C.; Kingsmore, S.F.; Schroth, G.P.; Burge, C.B. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456, 470-476.
3. Merkin, J.J.; Chen, P.; Alexis, M.S.; Hautaniemi, S.K.; Burge, C.B. Origins and impacts of new mammalian exons. Cell Rep. 2015, 10, 1992-2005.
4. Osborne, R.J.; Thornton, C.A. RNA-dominant diseases. Hum. Mol. Genet. 2006, 15, R162-R169.
5. O'Rourke, J.R.; Swanson, M.S. Mechanisms of RNA-mediated disease. J. Biol. Chem. 2009, 284, 7419-7423.
6. Ranum, L.P.; Cooper, T.A. RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci. 2006, 29, 259-277.
7. Lim, K.H.; Ferraris, L.; Filloux, M.E.; Raphael, B.J.; Fairbrother, W.G. Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes. Proc. Natl. Acad. Sci. USA 2011, 108, 11093-11098.
8. Jurica, M.S.; Moore, M.J. Pre-mRNA splicing: Awash in a sea of proteins. Mol. Cell 2003, 12, 5-14.
9. Roca, X.; Akerman, M.; Gaus, H.; Berdeja, A.; Bennett, C.F.; Krainer, A.R. Widespread recognition of 5' splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotides. Genes Dev. 2012, 26, 1098-109.
10. Hartmuth, K.; Urlaub, H.; Vornlocher, H.P.; Will, C.L.; Gentzel, M.; Wilm, M.; Luhrmann, R. Protein composition of human prespliceosomes isolated by a tobramycin affinity-selection method. Proc. Natl. Acad. Sci. USA 2002, 99, 16719-16724.
11. Zhou, Z.; Licklider, L.J.; Gygi, S.P.; Reed, R. Comprehensive proteomic analysis of the human spliceosome. Nature 2002, 419, 182-185.
12. Jurica, M.S.; Licklider, L.J.; Gygi, S.R.; Grigorieff, N.; Moore, M.J. Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA 2002, 8, 426-439.
13. Nilsen, T.W. The spliceosome: The most complex macromolecular machine in the cell? Bioessays 2003, 25, 1147-1149.
14. Kent, O.A.; Ritchie, D.B.; Macmillan, A.M. Characterization of a U2AF-independent commitment complex (E') in the mammalian spliceosome assembly pathway. Mol. Cell. Biol. 2005, 25, 233-240.
15. Zhang, Y.; Madl, T.; Bagdiul, I.; Kern, T.; Kang, H.S.; Zou, P.; Mausbacher, N.; Sieber, S.A.; Kramer, A.; Sattler, M. Structure, phosphorylation and U2AF65 binding of the N-terminal domain of splicing factor 1 during 3'-splice site recognition. Nucleic Acids Res. 2013, 41, 1343-1354.
16. Liang, W.W.; Cheng, S.C. A novel mechanism for Prp5 function in prespliceosome formation and proofreading the branch site sequence. Genes Dev. 2015, 29, 81-93.
17. Perriman, R.; Ares, M., Jr. Invariant U2 snRNA nucleotides form a stem loop to recognize the intron early in splicing. Mol. Cell 2010, 38, 416-427.
18. Matera, A.G.; Wang, Z. A day in the life of the spliceosome. Nat. Rev. Mol. Cell Biol. 2014, 15, 108-121.
19. Mohlmann, S.; Mathew, R.; Neumann, P.; Schmitt, A.; Luhrmann, R.; Ficner, R. Structural and functional analysis of the human spliceosomal DEAD-box helicase Prp28. Acta Crystallogr. D Biol. Crystallogr. 2014, 70, 1622-1630.
20. Zhang, L.; Li, X.; Hill, R.C.; Qiu, Y.; Zhang, W.; Hansen, K.C.; Zhao, R. Brr2 plays a role in spliceosomal activation in addition to U4/U6 unwinding. Nucleic Acids Res. 2015, 43, 3286-3297.
21. Nancollis, V.; Ruckshanthi, J.P.; Frazer, L.N.; O'Keefe, R.T. The U5 snRNA internal loop 1 is a platform for Brr2, Snu114 and Prp8 protein binding during U5 snRNP assembly. J. Cell. Biochem. 2013, 114, 2770-2784.
22. Wlodaver, A.M.; Staley, J.P. The DExD/H-box ATPase Prp2p destabilizes and proofreads the catalytic RNA core of the spliceosome. RNA 2014, 20, 282-294.
23. Lardelli, R.M.; Thompson, J.X.; Yates, J.R., 3rd; Stevens, S.W. Release of SF3 from the intron branchpoint activates the first step of pre-mRNA splicing. RNA 2010, 16, 516-528.
24. Galej, W.P.; Oubridge, C.; Newman, A.J.; Nagai, K. Crystal structure of Prp8 reveals active site cavity of the spliceosome. Nature 2013, 493, 638-643.
25. Fica, S.M.; Tuttle, N.; Novak, T.; Li, N.S.; Lu, J.; Koodathingal, P.; Dai, Q.; Staley, J.P.; Piccirilli, J.A. RNA catalyses nuclear pre-mRNA splicing. Nature 2013, 503, 229-234.
26. Piccolo, L.L.; Corona, D.; Onorati, M.C. Emerging roles for hnRNPs in post-transcriptional regulation: What can we learn from flies? Chromosoma 2014, 123, 515-527.
27. Matunis, E.L.; Matunis, M.J.; Dreyfuss, G. Characterization of the major hnRNP proteins from Drosophila melanogaster. J. Cell Biol. 1992, 116, 257-269.
28. Martinez-Contreras, R.; Cloutier, P.; Shkreta, L.; Fisette, J.F.; Revil, T.; Chabot, B. hnRNP proteins and splicing control. Adv. Exp. Med. Biol. 2007, 623, 123-147.
29. Han, S.P.; Tang, Y.H.; Smith, R. Functional diversity of the hnRNPs: Past, present and perspectives. Biochem. J. 2010, 430, 379-392.
30. Han, N.; Li, W.; Zhang, M. The function of the RNA-binding protein hnRNP in cancer metastasis. J. Cancer Res. Ther. 2013, 9, S129-S134.
31. Rollins, C.; Levengood, J.D.; Rife, B.D.; Salemi, M.; Tolbert, B.S. Thermodynamic and phylogenetic insights into hnRNP A1 recognition of the HIV-1 exon splicing silencer 3 element. Biochemistry 2014, 53, 2172-2184.
32. Rooke, N.; Markovtsov, V.; Cagavi, E.; Black, D.L. Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1. Mol. Cell. Biol. 2003, 23, 1874-1884.
33. Zahler, A.M.; Lane, W.S.; Stolk, J.A.; Roth, M.B. SR proteins: A conserved family of pre-mRNA splicing factors. Genes Dev. 1992, 6, 837-847.
34. Roth, M.B.; Murphy, C.; Gall, J.G. A monoclonal antibody that recognizes a phosphorylated epitope stains lampbrush chromosome loops and small granules in the amphibian germinal vesicle. J. Cell Biol. 1990, 111, 2217-2223.
35. Ge, H.; Zuo, P.; Manley, J.L. Primary structure of the human splicing factor ASF reveals similarities with Drosophila regulators. Cell 1991, 66, 373-382.
36. Krainer, A.R.; Mayeda, A.; Kozak, D.; Binns, G. Functional expression of cloned human splicing factor SF2: Homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators. Cell 1991, 66, 383-394.
37. Ge, H.; Manley, J.L. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell 1990, 62, 25-34.
38. Chou, T.B.; Zachar, Z.; Bingham, P.M. Developmental expression of a regulatory gene is programmed at the level of splicing. EMBO J. 1987, 6, 4095-4104.
39. Boggs, R.T.; Gregor, P.; Idriss, S.; Belote, J.M.; McKeown, M. Regulation of sexual differentiation in D. melanogaster via alternative splicing of RNA from the transformer gene. Cell 1987, 50, 739-747.
40. Amrein, H.; Gorman, M.; Nothiger, R. The sex-determining gene tra-2 of Drosophila encodes a putative RNA binding protein. Cell 1988, 55, 1025-1035.
41. Shepard, P.J.; Hertel, K.J. The SR protein family. Genome Biol. 2009, 10, 242.
42. Busch, A.; Hertel, K.J. Evolution of SR protein and hnRNP splicing regulatory factors. Wiley Interdiscip. Rev. RNA 2012, 3, 1-12.
43. Cho, S.; Hoang, A.; Sinha, R.; Zhong, X.Y.; Fu, X.D.; Krainer, A.R.; Ghosh, G. Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly. Proc. Natl. Acad. Sci. USA 2011, 108, 8233-8238.
44. Zhou, Z.; Fu, X.D. Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma 2013, 122, 191-207.
45. Schneider, M.; Will, C.L.; Anokhina, M.; Tazi, J.; Urlaub, H.; Luhrmann, R. Exon definition complexes contain the tri-snRNP and can be directly converted into B-like precatalytic splicing complexes. Mol. Cell 2010, 38, 223-235.
46. Furuyama, S.; Bruzik, J.P. Multiple roles for SR proteins in trans splicing. Mol. Cell. Biol. 2002, 22, 5337-5346.
47. Neumann, M.; Bentmann, E.; Dormann, D.; Jawaid, A.; DeJesus-Hernandez, M.; Ansorge, O.; Roeber, S.; Kretzschmar, H.A.; Munoz, D.G.; Kusaka, H.; et al. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 2011, 134, 2595-2609.
48. Deng, H.; Gao, K.; Jankovic, J. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol. 2014, 10, 337-348.
49. Girard, C.; Will, C.L.; Peng, J.; Makarov, E.M.; Kastner, B.; Lemm, I.; Urlaub, H.; Hartmuth, K.; Luhrmann, R. Post-transcriptional spliceosomes are retained in nuclear speckles until splicing completion. Nat. Commun. 2012, 3, 994.
50. Eng, L.; Coutinho, G.; Nahas, S.; Yeo, G.; Tanouye, R.; Babaei, M.; Dork, T.; Burge, C.; Gatti, R.A. Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: Maximum entropy estimates of splice junction strengths. Hum. Mutat. 2004, 23, 67-76.
51. Xia, K.; Zheng, D.; Pan, Q.; Liu, Z.; Xi, X.; Hu, Z.; Deng, H.; Liu, X.; Jiang, D.; Deng, H.; et al. A novel PRPF31 splice-site mutation in a Chinese family with autosomal dominant retinitis pigmentosa. Mol. Vis. 2004, 10, 361-365.
52. Hartikainen, J.M.; Pirskanen, M.M.; Arffman, A.H.; Ristonmaa, U.K.; Mannermaa, A.J. A Finnish BRCA1 exon 12 4216-2nt A to G splice acceptor site mutation causes aberrant splicing and frameshift, leading to protein truncation. Hum. Mutat. 2000, 15, 120.
53. Sun, H.; Chasin, L.A. Multiple splicing defects in an intronic false exon. Mol. Cell. Biol. 2000, 20, 6414-6425.
54. Burrows, N.P.; Nicholls, A.C.; Richards, A.J.; Luccarini, C.; Harrison, J.B.; Yates, J.R.; Pope, F.M. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families. Am. J. Hum. Genet. 1998, 63, 390-398.
55. Crotti, L.B.; Horowitz, D.S. Exon sequences at the splice junctions affect splicing fidelity and alternative splicing. Proc. Natl. Acad. Sci. USA 2009, 106, 18954-18959.
56. Maslen, C.; Babcock, D.; Raghunath, M.; Steinmann, B. A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly. Am. J. Hum. Genet. 1997, 60, 1389-1398.
57. Taggart, A.J.; DeSimone, A.M.; Shih, J.S.; Filloux, M.E.; Fairbrother, W.G. Large-scale mapping of branchpoints in human pre-mRNA transcripts in vivo. Nat. Struct. Mol. Biol. 2012, 19, 719-721.
58. Zhang, X.H.; Chasin, L.A. Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev. 2004, 18, 1241-1250.
59. Ray, D.; Kazan, H.; Cook, K.B.; Weirauch, M.T.; Najafabadi, H.S.; Li, X.; Gueroussov, S.; Albu, M.; Zheng, H.; Yang, A.; et al. A compendium of RNA-binding motifs for decoding gene regulation. Nature 2013, 499, 172-177.
60. Martinez-Contreras, R.; Fisette, J.F.; Nasim, F.U.; Madden, R.; Cordeau, M.; Chabot, B. Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing. PLoS Biol. 2006, 4, e21.
61. Kanopka, A.; Muhlemann, O.; Akusjarvi, G. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature 1996, 381, 535-538.
62. Faa, V.; Coiana, A.; Incani, F.; Costantino, L.; Cao, A.; Rosatelli, M.C. A synonymous mutation in the CFTR gene causes aberrant splicing in an italian patient affected by a mild form of cystic fibrosis. J. Mol. Diagn. 2010, 12, 380-383.
63. Sterne-Weiler, T.; Howard, J.; Mort, M.; Cooper, D.N.; Sanford, J.R. Loss of exon identity is a common mechanism of human inherited disease. Genome Res. 2011, 21, 1563-1571.
64. Kuyumcu-Martinez, N.M.; Wang, G.S.; Cooper, T.A. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell 2007, 28, 68-78.
65. Dredge, B.K.; Polydorides, A.D.; Darnell, R.B. The splice of life: Alternative splicing and neurological disease. Nat. Rev. Neurosci. 2001, 2, 43-50.
66. Arnold, E.S.; Ling, S.C.; Huelga, S.C.; Lagier-Tourenne, C.; Polymenidou, M.; Ditsworth, D.; Kordasiewicz, H.B.; McAlonis-Downes, M.; Platoshyn, O.; Parone, P.A.; et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl. Acad. Sci. USA 2013, 110, E736-E745.
67. Guo, W.; Schafer, S.; Greaser, M.L.; Radke, M.H.; Liss, M.; Govindarajan, T.; Maatz, H.; Schulz, H.; Li, S.; Parrish, A.M.; et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat. Med. 2012, 18, 766-773.
68. Fogel, B.L.; Wexler, E.; Wahnich, A.; Friedrich, T.; Vijayendran, C.; Gao, F.; Parikshak, N.; Konopka, G.; Geschwind, D.H. RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum. Mol. Genet. 2012, 21, 4171-4186.
69. Zhang, J.; Manley, J.L. Misregulation of pre-mRNA alternative splicing in cancer. Cancer Discov. 2013, 3, 1228-1237.
70. Anczukow, O.; Rosenberg, A.Z.; Akerman, M.; Das, S.; Zhan, L.; Karni, R.; Muthuswamy, S.K.; Krainer, A.R. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat. Struct. Mol. Biol. 2012, 19, 220-228.
71. Yeo, G.; Burge, C.B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 2004, 11, 377-394.
72. Brunak, S.; Engelbrecht, J.; Knudsen, S. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J. Mol. Biol. 1991, 220, 49-65.
73. Fairbrother, W.G.; Yeo, G.W.; Yeh, R.; Goldstein, P.; Mawson, M.; Sharp, P.A.; Burge, C.B. RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons. Nucleic Acids Res. 2004, 32, W187-W190.
74. Goren, A.; Kim, E.; Amit, M.; Vaknin, K.; Kfir, N.; Ram, O.; Ast, G. Overlapping splicing regulatory motifs-combinatorial effects on splicing. Nucleic Acids Res. 2010, 38, 3318-3327.
75. Lim, K.H.; Fairbrother, W.G. Spliceman-A computational web server that predicts sequence variations in pre-mRNA splicing. Bioinformatics 2012, 28, 1031-1032.
76. Consortium, G.T. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 2013, 45, 580-585.
77. Cooper, T.A. Use of minigene systems to dissect alternative splicing elements. Methods 2005, 37, 331-340.
78. Basler, K.; Siegrist, P.; Hafen, E. The spatial and temporal expression pattern of sevenless is exclusively controlled by gene-internal elements. EMBO J. 1989, 8, 2381-2386.
79. Soemedi, R.; Vega, H.; Belmont, J.M.; Ramachandran, S.; Fairbrother, W.G. Genetic variation and RNA binding proteins: Tools and techniques to detect functional polymorphisms. Adv. Exp. Med. Biol. 2014, 825, 227-266.
80. Licatalosi, D.D.; Mele, A.; Fak, J.J.; Ule, J.; Kayikci, M.; Chi, S.W.; Clark, T.A.; Schweitzer, A.C.; Blume, J.E.; Wang, X.; et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 2008, 456, 464-469.
81. Hua, Y.; Sahashi, K.; Rigo, F.; Hung, G.; Horev, G.; Bennett, C.F.; Krainer, A.R. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 2011, 478, 123-126.
82. Hua, Y.; Sahashi, K.; Hung, G.; Rigo, F.; Passini, M.A.; Bennett, C.F.; Krainer, A.R. Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev. 2010, 24, 1634-1644.
83. Svasti, S.; Suwanmanee, T.; Fucharoen, S.; Moulton, H.M.; Nelson, M.H.; Maeda, N.; Smithies, O.; Kole, R. RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice. Proc. Natl. Acad. Sci. USA 2009, 106, 1205-1210.
84. Lundin, K.E.; Hojland, T.; Hansen, B.R.; Persson, R.; Bramsen, J.B.; Kjems, J.; Koch, T.; Wengel, J.; Smith, C.I. Biological activity and biotechnological aspects of locked nucleic acids. Adv. Genet. 2013, 82, 47-107.
85. Owen, N.; Zhou, H.; Malygin, A.A.; Sangha, J.; Smith, L.D.; Muntoni, F.; Eperon, I.C. Design principles for bifunctional targeted oligonucleotide enhancers of splicing. Nucleic Acids Res. 2011, 39, 7194-7208.
86. Disterer, P.; Kryczka, A.; Liu, Y.; Badi, Y.E.; Wong, J.J.; Owen, J.S.; Khoo, B. Development of therapeutic splice-switching oligonucleotides. Hum. Gene Ther. 2014, 25, 587-598.
87. Hastings, M.L.; Berniac, J.; Liu, Y.H.; Abato, P.; Jodelka, F.M.; Barthel, L.; Kumar, S.; Dudley, C.; Nelson, M.; Larson, K.; et al. Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy. Sci. Transl. Med. 2009, doi:10.1126/scitranslmed.3000208.
88. Wheeler, T.M.; Sobczak, K.; Lueck, J.D.; Osborne, R.J.; Lin, X.; Dirksen, R.T.; Thornton, C.A. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 2009, 325, 336-339.
89. Mulders, S.A.; van den Broek, W.J.; Wheeler, T.M.; Croes, H.J.; van Kuik-Romeijn, P.; de Kimpe, S.J.; Furling, D.; Platenburg, G.J.; Gourdon, G.; Thornton, C.A.; et al. Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc. Natl. Acad. Sci. USA 2009, 106, 13915-13920.
90. Lee, J.E.; Bennett, C.F.; Cooper, T.A. RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1. Proc. Natl. Acad. Sci. USA 2012, 109, 4221-4226.
91. Leger, A.J.; Mosquea, L.M.; Clayton, N.P.; Wu, I.H.; Weeden, T.; Nelson, C.A.; Phillips, L.; Roberts, E.; Piepenhagen, P.A.; Cheng, S.H.; et al. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy. Nucleic Acid Ther. 2013, 23, 109-117.
92. Wheeler, T.M.; Leger, A.J.; Pandey, S.K.; MacLeod, A.R.; Nakamori, M.; Cheng, S.H.; Wentworth, B.M.; Bennett, C.F.; Thornton, C.A. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 2012, 488, 111-115.
93. Francois, V.; Klein, A.F.; Beley, C.; Jollet, A.; Lemercier, C.; Garcia, L.; Furling, D. Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs. Nat. Struct. Mol. Biol. 2011, 18, 85-87.
94. Sobczak, K.; Wheeler, T.M.; Wang, W.; Thornton, C.A. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy. Mol. Ther. 2013, 21, 380-387.
95. Warf, M.B.; Nakamori, M.; Matthys, C.M.; Thornton, C.A.; Berglund, J.A. Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc. Natl. Acad. Sci. USA 2009, 106, 18551-18556.
96. Garcia-Lopez, A.; Llamusi, B.; Orzaez, M.; Perez-Paya, E.; Artero, R.D. In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models. Proc. Natl. Acad. Sci. USA 2011, 108, 11866-11871.
97. Childs-Disney, J.L.; Parkesh, R.; Nakamori, M.; Thornton, C.A.; Disney, M.D. Rational design of bioactive, modularly assembled aminoglycosides targeting the RNA that causes myotonic dystrophy type 1. ACS Chem. Biol. 2012, 7, 1984-1993.
98. Zhang, W.; Wang, Y.; Dong, S.; Choudhury, R.; Jin, Y.; Wang, Z. Treatment of type 1 myotonic dystrophy by engineering site-specific RNA endonucleases that target (CUG)(n) repeats. Mol. Ther. 2014, 22, 312-320.